Please login to the form below

Not currently logged in
Email:
Password:

psoriasis

This page shows the latest psoriasis news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s upadacitinib aces phase III trial

AbbVie’s upadacitinib aces phase III trial

phase III results in psoriasis in February.

Latest news

More from news
Approximately 58 fully matching, plus 234 partially matching documents found.

Latest Intelligence

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    costs. It was then backed with a ‘no response-no payment’contract. It has also struck novel reimbursement packages with its heart failure therapy Entresto and its psoriasis treatment Cosentyx.

  • Digital health Digital health

    In December 2016, Amalgam announced a partnership with UCB on a comprehensive behavioural and patient support programme for patients living with psoriasis. ... We went to the medical and behavioural literature to find out what has been shown to help

  • The good, the bad and the ugly The good, the bad and the ugly

    Elsewhere, Celgene has seen large growth in 2017 (46%) - driven by sales of Otezla, the first oral small molecule to be approved for psoriasis and psoriatic arthritis. ... Similarly, Novartis has enjoyed 31.7% growth thanks to another psoriasis/psoriatic

  • Pharma deals continue to slide Pharma deals continue to slide

    Pre-registration (US) topical high potency steroid for moderate to severe plaque psoriasis.

  • Embracing digital disruption in pharma Embracing digital disruption in pharma

    Imagine is a psoriasis tracking app, where users can document how the severity of a psoriasis lesion develops over time. ... HelloSkin is the number one online store for emollients, nutrition supplements, accessories and selected over-the-counter

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Millefeuille

    Millefeuille. This story of hope charts Élodie’ s physical and mental struggles with psoriasis and psoriatic arthritis. ... For more information please visit http://bedrock-health.com/millefeuille/. Millefeuille. This story of hope charts Élodie’ s

  • What next for the treatment of Psoriasis in Europe?

    What next for the treatment of Psoriasis in Europe? Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe. ... Over the last decade, systemic biologic therapies for Psoriasis (PsO) have become widespread and

  • Research Partnership launches new patient Living with Psoriasis 2017 (EU) report

    Research Partnership launches new patient Living with Psoriasis 2017 (EU) report. ... Living with Psoriasis is a study conducted amongst 615 patients in Europe.

  • Research Partnership has published a new patient Living with Psoriasis (EU) report

    Living with Psoriasis is a report based on a new study conducted in the main 5EU markets and Belgium and the Netherlands (reports can be purchased for either 5EU or 7EU). ... The 7EU report has an additional 100 quantitative interviews. An attitudinal

  • AAD conference 2016

    The poster, which is entitled: ‘ A real word review of treatment duration and persistence among European psoriasis patients’ is authored by Research Director, Laurent Chanroux and Research Executive, Lauren Royel.

More from PMHub
Approximately 6 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics